SF17 Therapeutics

SF17 Therapeutics is a pharmaceutical company that aims to develop innovative therapeutics for patients affected by inflammation- and immune system-related diseases. The company uses an advanced technology called the AI + Immunology Discovery Engine (AIDE Engine), which applies machine learning and neural networks to analyze immune tissue samples from patients. This enables the discovery of new and effective drug targets, which can help healthcare providers treat their patients and improve their quality of life.